Epitrate Injection 1 ml
Marketer
Sunways India Pvt Ltd
Salt Composition
Adrenaline (1mg) + Sodium Metabisulphite (0.1% w/v)
Overview Epitrate Injection 1 ml
One milliliter of Epitrate Injection is a combined-drug formulation employed for mydriasis. Its mechanism involves ocular muscle relaxation, resulting in pupil dilation. Administration is strictly via intramuscular injection under a physician's direct supervision; self-injection is prohibited. Dosage and treatment length are solely determined by your doctor. Adhere meticulously to their prescribed regimen. Commonly reported adverse effects include nausea, vomiting, and elevated blood pressure; while usually mild, persistent or bothersome symptoms necessitate immediate medical consultation. Dizziness is a potential side effect; operating machinery or driving should be avoided during treatment. Prior to commencing therapy, disclose any pre-existing liver or kidney conditions, pregnancy, or breastfeeding status to your physician. Complete transparency regarding all concurrently used medications is crucial, as interactions are possible.
Uses of Epitrate Injection 1 ml
Mydriasis
Major Benefits of Epitrate Injection 1 ml:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Epitrate Injection 1 ml:
- Nausea
- Vomiting
- High blood pressure
- Increased heart rate
How to use Epitrate Injection 1 ml:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Epitrate Injection 1 ml works:
Epitrate Injection, a 1 ml solution, combines adrenaline with sodium metabisulphite. Adrenaline, acting as an alpha- and beta-adrenergic agonist, facilitates mydriasis and ocular muscle relaxation, improving surgical visualization. The sodium metabisulphite functions as a preservative, enhancing adrenaline's stability and preventing discoloration within the injection.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Epitrate Injection 1 ml may be unsafe; physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Use of Epitrate Injection 1 ml during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Epitrate Injection 1 ml use while breastfeeding is absent. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
The effect of a 1 ml Epitrate Injection on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of 1 ml Epitrate Injection to individuals with renal impairment. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of one milliliter of Epitrate Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Epitrate Injection 1 ml :
NA
Facts to Know About Epitrate Injection 1 ml
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |





